Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

FHTX

Foghorn Therapeutics (FHTX)

Foghorn Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:FHTX
FechaHoraFuenteTítuloSímboloCompañía
28/05/202406:00GlobeNewswire Inc.Foghorn Therapeutics to Participate in Upcoming Investor Conferences in JuneNASDAQ:FHTXFoghorn Therapeutics Inc
23/05/202406:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FHTXFoghorn Therapeutics Inc
22/05/202417:21GlobeNewswire Inc.Foghorn Therapeutics Raises Approximately $110 Million Through Registered Direct Offering to Advance PipelineNASDAQ:FHTXFoghorn Therapeutics Inc
20/05/202415:31Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:FHTXFoghorn Therapeutics Inc
06/05/202406:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FHTXFoghorn Therapeutics Inc
06/05/202406:03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FHTXFoghorn Therapeutics Inc
07/03/202406:09Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:FHTXFoghorn Therapeutics Inc
25/01/202415:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FHTXFoghorn Therapeutics Inc
27/11/202318:01PR Newswire (US)Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science LeadersNASDAQ:FHTXFoghorn Therapeutics Inc
21/11/202305:00PR Newswire (US)Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of GeneticsNASDAQ:FHTXFoghorn Therapeutics Inc
01/11/202309:30PR Newswire (US)Flagship Pioneering Launches Pioneering IntelligenceNASDAQ:FHTXFoghorn Therapeutics Inc
11/09/202305:30PR Newswire (US)Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development OfficerNASDAQ:FHTXFoghorn Therapeutics Inc
05/09/202307:00GlobeNewswire Inc.Foghorn Therapeutics Announces Participation in Upcoming Investor ConferencesNASDAQ:FHTXFoghorn Therapeutics Inc
31/08/202306:00GlobeNewswire Inc.Foghorn Therapeutics Announces First Patient Dosed in Phase 1 Combination Study of FHD-286 for Relapsed and/or Refractory AMLNASDAQ:FHTXFoghorn Therapeutics Inc
29/08/202308:00PR Newswire (US)Invaio achieves first registration for citrus greening solution featuring Trecise™ technologyNASDAQ:FHTXFoghorn Therapeutics Inc
08/08/202306:00GlobeNewswire Inc.Foghorn Therapeutics Announces Chief Medical Officer SuccessionNASDAQ:FHTXFoghorn Therapeutics Inc
04/08/202306:00GlobeNewswire Inc.Foghorn Therapeutics Provides Second Quarter 2023 Financial and Corporate UpdateNASDAQ:FHTXFoghorn Therapeutics Inc
28/06/202306:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FHTXFoghorn Therapeutics Inc
28/06/202306:00GlobeNewswire Inc.Foghorn Therapeutics Announces Clinical Data from Phase 1 Study of FHD-286 in Metastatic Uveal MelanomaNASDAQ:FHTXFoghorn Therapeutics Inc
05/06/202307:07Dow Jones NewsFoghorn Therapeutics Shares Rally Premarket as FDA Lifts Clinical HoldNASDAQ:FHTXFoghorn Therapeutics Inc
16/05/202305:00PR Newswire (US)Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of BiomimicryNASDAQ:FHTXFoghorn Therapeutics Inc
08/05/202306:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FHTXFoghorn Therapeutics Inc
08/05/202306:06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FHTXFoghorn Therapeutics Inc
28/04/202315:07Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:FHTXFoghorn Therapeutics Inc
28/04/202315:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FHTXFoghorn Therapeutics Inc
22/02/202315:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FHTXFoghorn Therapeutics Inc
09/02/202310:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FHTXFoghorn Therapeutics Inc
21/11/202210:35TipRanksMorgan Stanley Keeps Their Hold Rating on Foghorn Therapeutics (FHTX)NASDAQ:FHTXFoghorn Therapeutics Inc
09/11/202205:25TipRanksH.C. Wainwright Sticks to Its Buy Rating for Foghorn Therapeutics (FHTX)NASDAQ:FHTXFoghorn Therapeutics Inc
31/10/202215:02Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FHTXFoghorn Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:FHTX

Su Consulta Reciente

Delayed Upgrade Clock